VCP
PMD

Verus Capital Partners’s Psychemedics Corporation PMD Stock Holding History

Verus Capital Partners’s Portfolio PMD Stock Details PMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$23K Sell
3,865
-2,250
-37% -$19K 0.01% 773
2019
Q4 		$56K Buy
+6,115
New +$56.5K 0.02% 566

Other funds holding PMD

KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CIC
Crawford Investment Counsel Atlanta, Georgia $5.85B AUM 12.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Verus Capital Partners's PMD Position: Q1 2020 in Review

Verus Capital Partners reduced its Psychemedics Corporation (PMD) stake by 37% in Q1 2020, selling an estimated $19K and leaving 3,865 shares worth $23K. The position accounts for 0.01% of the portfolio, ranked #773.

Verus Capital Partners first reported a position in PMD in Q4 2019 and has held it in 2 quarters since. The position peaked at $56K in Q4 2019. 37 funds tracked by Wall St. Rank hold PMD as of Q1 2020.

  • Verus Capital Partners held 3,865 shares of Psychemedics Corporation worth $23K as of Q1 2020.
  • Verus Capital Partners sold 2,250 Psychemedics Corporation shares in Q1 2020, an estimated $19K.
  • Psychemedics Corporation made up 0.01% of Verus Capital Partners's portfolio in Q1 2020, its #773 holding.
  • Verus Capital Partners first reported a position in Psychemedics Corporation in Q4 2019 and has held it in 2 quarters since.
  • Verus Capital Partners's Psychemedics Corporation position peaked at $56K in Q4 2019.
  • 37 funds tracked by Wall St. Rank held Psychemedics Corporation as of Q1 2020.

Based on Verus Capital Partners's 13F filing for Q1 2020, filed 26 May 2020.